The role of transforming growth factor beta in bicuspid aortic valve aortopathy

Indian J Thorac Cardiovasc Surg. 2023 Dec;39(Suppl 2):270-279. doi: 10.1007/s12055-023-01513-8. Epub 2023 May 25.

Abstract

A bicuspid aortic valve (BAV) is the most prevalent congenital cardiac deformity, which is associated with an increased risk to develop a thoracic aortic aneurysm and/or an aortic dissection as compared to persons with a tricuspid aortic valve. Due to the high prevalence of a BAV in the general population and the associated life-long increased risk for adverse vascular events, BAV disease places a considerable burden on the public health. The aim of the present review is to discuss the role of transforming growth factor beta (TGF-β) signaling in the development of the vascular wall and on how this complex signaling pathway may be involved in thoracic aortic aneurysm formation in tricuspid and BAV patients.

Keywords: Bicuspid aortic valve; Embryology; Molecular biology; TGF-β; Thoracic aortopathy.